TAB C 
CHARTER 
INTERAGENCY CO-CriTTEE Oil RECCC SINAI IT DNA RESEARCH 
Purporfl 
To coordinate Federal program* end activities relating to reconb Inant 
deoxyribonucleic ccid (DNA) research, to arslst in facilitating 
compliance with a uniform set of guidelines for the conduct of this 
research in the public and private uectora and to facilitate communication 
and exchange of information auong CovniTJccnt agencies. 
Authority 
This Committee is established pursuant to a memorandum of September 22 
from the President to all Department and Agency Heads and a letter of 
October 1 from the Secretary of Health, Education, and Welfare. This 
Cocmlttee is excluded from provisions of Public Lav 92-463 vhlch 6eta 
forth standards for the formation and use of Advisory Committees. 
Function 
The Interagency Committee on Recombinant HHA Research shall advise the 
Secretary, the Assistant Secretary for Health, and the Director, National 
Institutes of Health, on the coordination of those aspects of all Federal 
programs and activities relating to recombinant DNA research. The 
Committee shall provide for tha full coimunication and exchange of 
information necessary to maintain adcouato coordination of such programs 
and activities. The Committee shall be responsible for facilitating 
compliance vith a uniform oct of guidelines in the conduct of this 
research in the public and private sectors and, where warranted, suggest 
administrative or legislative proposals. 
Structure 
The Director of the Notional Institutes of Health shall serve as Chairman 
of the Committee and the Coralttee shall include representation from all 
Departments and Agencies whose programs involve health functions or 
responsibilities as determined by the Secretary. 
[ 181 ] 
